글로벌 울혈성 신부전(CRF) 시장 – 2029년까지의 산업 동향 및 예측

울혈성 신부전(CRF) 시장 분석 및 규모

글로벌 울혈성 신부전(CRF) 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 국내총생산(GDP)과 증가하는 인플레이션율과 같은 요인이 CRF 시장의 발전에 영향을 미칠 것으로 예상됩니다. 전 세계적으로 증가하는 신부전 유병률과 진화하는 시장은 이 시장 성장의 원인입니다. COVID-19도 울혈성 신부전(CRF) 시장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 울혈성 신부전(CRF) 시장의 성장률을 분석합니다. 글로벌 울혈성 신부전(CRF) 시장은 언급된 예측 기간 동안 건강한 CAGR을 보일 것으로 예상됩니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함됩니다.

시장 정의

울혈성 신부전은 신장이 혈액에서 노폐물을 충분히 걸러내지 못하는 말기 신부전입니다. 심혈관 혈관 질환(울혈성 심부전 및 고혈압 등) 및 신부전 가족력을 ​​포함한   기타 신장 질환 으로 인해 발생할 수 있습니다.

울혈성 신부전(CRF) 시장 범위 및 세분화

Global Congestive Renal Failure (CRF) Market Dynamics

Drivers

• Increasing Incidence of Kidney Diseases

Chronic kidney disease (CKD) serves as a strong and independent risk factor for cardiovascular disease (CVD). For instance, the prevalence of CVD in CKD patients reaches 63%, in U.S. in contrast with only 5.8% in people without CKD, and this margin is directly correlated with the adversity of CKD.

• Government Initiatives

The market is expected to grow rapidly in the mentioned forecast period due to the increasing incidence and prevalence of kidney diseases in the elderly. Key companies taking the initiative in the development of new drugs and therapies for the treatment associated with various pipeline drugs is expected to boost the market growth.  

Opportunities

• Rising Incidence of Hypertension and Diabetes

According to the WHO 2019, approximately 1.13 billion people worldwide have hypertension. In the year range 2014–2016, diabetes and hypertension were responsible for nearly 75% of kidney failure. Diabetes is the major cause of advanced kidney disease, followed by hypertension, which is estimated to affect around 1 billion population globally. Hence, this factor is creating much opportunity in the global congestive renal failure market.

• Advanced Clinical Research and Technological Advancement

Advancements in the technology used in the treatment for congestive renal failure are aiding in providing better care and satisfaction along with the outstanding results are boosting the consumption and growth of the congestive renal failure market

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to perform the treatment could curb the growth of the global congestive renal failure (CRF) market over a forecast period.

• High Cost

The huge expenditure required for the surgeries or the treatment surely hamper the market growth.

This global congestive renal failure (CRF) market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global congestive renal failure (CRF) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Congestive Renal Failure (CRF) Market  

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.

In the post-pandemic era, COVID-19 is expected to positively impact the congestive renal failure (CRF) market, attributing to the increasing number of comorbid diseases such as diabetes or end-stage renal disease market (ESRD).  

Global Congestive Renal Failure (CRF) Market Scope

The global congestive renal failure (CRF) market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• CRF With Cardiorenal Syndrome
• CRF With Non-Cardiorenal Syndrome
• Others

Treatment

• Surgery
• Medication
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-User

• Hospitals
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

Congestive Renal Failure (CRF) Market Regional Analysis/Insights

The global congestive renal failure (CRF) market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global congestive renal failure (CRF) market  report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America holds the largest market share due to increased smoking & obesity which causes infection in kidney, growing population with kidney dysfunction.

Asia-Pacific is expected to hold the largest market share due to increased prevalence of kidney damage, increasing population with dialysis treatment and increasing initiatives by government & pharmaceutical organizations to spread awareness.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Congestive Renal Failure (CRF) Market Share Analysis

글로벌 울혈성 신부전(CRF) 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 울혈성 신부전(CRF) 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 울혈성 신부전(CRF) 시장에서 활동하는 주요 기업은 다음과 같습니다.

• GlaxoSmithKline Plc. (영국)
• Sun Pharmaceutical Industries Ltd(인도)
• 노바티스 AG(스위스)
• 마일런 NV(미국)
• 루팡(인도)
• Teva Pharmaceutical Industries Ltd. (이스라엘)

SKU-53520